# Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer

> **NCT00551889** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 57 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** celecoxib
- **DRUG:** cyclophosphamide
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00551889
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2012-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00551889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00551889, "Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00551889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*